BL-B01D1 Antibody
BL-B01D1 is a bispecific antibody-drug conjugate (ADC) targeting EGFR and HER3 via Izalontamab, delivering the cytotoxic payload ED04 to disrupt DNA replication. It is utilized in oncology research for investigating antitumor activity in both in vitro cell assays and in vivo xenograft models.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog